Forward P/E Multiple: Cencora, Inc. (COR)

Brandmark of Cencora, Inc. (COR)

Cencora, Inc. (COR) forward P/E ratio demonstrates a dependence on generic drug costs and logistics efficiency, with the parameter stabilizing at 16.60. Margin stability is supported by broad market coverage across the US and Europe. Business development is based on dosing automation and the implementation of RFID systems for the transportation of complex medical preparations.

COR - Cencora Projected Price to Earnings Ratio over the range 02/21/2024 - 11/14/2026

Metric breakdowns and analytics for AmerisourceBergen Corporation (COR)

- current price and projected stock value:
Stock Quotes Cencora|COR - Average Forecast Price
- company stock exchange capitalization indicators:
Market Capitalization Cencora Inc|COR - Real Price to Acquire Entire Company
- book capitalization information:
Book Value per Share Cencora|COR - Total Stockholders' Equity|Market Value to Book Value Ratio cencora.com|COR - Total Business Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Cencora, Inc.|COR - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Cencora, Inc.|COR - Company Cumulative Debt|Debt to Book Capitalization Ratio Cencora Inc|COR - Company Long-Term Loans and Borrowings|Company Short-Term Debts Cencora|Quick Liquidity Indicator cencora.com
- earnings and market ratios statistics:
COR - Final Profit|Projected Future Earnings Cencora, Inc.|COR - Business Payback Period|Future Price to Earnings AmerisourceBergen|COR - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Cencora Inc|COR - Operating profit before deduction of amortization|Net earnings per share for the last 12 months Cencora|COR - Net earnings per share for the last four quarters|Quarterly EPS earnings growth cencora.com|COR - Net earnings per share growth this year|Net earnings per share growth forecast for next year Cencora, Inc.
- sales and revenue data:
COR - Company Total Revenue|Company Projected Revenue Cencora|COR - Market Capitalization-to-Revenue Ratio|Price-to-Projected Revenue Ratio Cencora Inc
Analysis of all company metrics:COR Cencora
Brand item of Cencora, Inc.

The stability of the core workforce and targeted enhancements of IT competencies in Cencora, Inc. (COR) logistics ensure the predictability of operational flows. By analyzing the company's forward P/E ratio, an investor observes the asset's market value relative to projected net income. This indicator measures the premium the market is willing to pay for future earnings. The trend of the curve allows for the identification of overvaluation risks should the cost of capital change. This determines the long-term consensus regarding the fundamental value of the business.

Direct competitors

Projected Price to Earnings CVS (CVS Health Corporation)|MCK - Projected Price to Earnings Ratio|Forward P/E Multiple CAH (Cardinal Health Corp)|HSIC - Projected Price to Earnings|Prestige Consumer Healthcare - Forward P/E Multiple|Projected Price to Earnings Ratio Wellgistics Health Inc|111.com.cn (YI) - Future Price to Earnings|Price to Future Earnings Ratio RDGT|UPC (Universe Pharmacy) - Forward P/E Multiple|Projected Price to Earnings Biodexa Pharma (BDRX)|Future Price to Earnings Hong Kong Pharma Digital (HKPD)|BIMI - Projected Price to Earnings Ratio|Future Price to Earnings China Jo-Jo Drugstores, Inc. CJJD|Future Price to Earnings Multiple WBA